好色先生

好色先生

Explore the latest content from across our publications

Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Predicting the End of Symptomatic Relapses and Disease Modifying Treatment Use Decisions in Progressive Multiple Sclerosis
Multiple Sclerosis
(-)
001
Authors/Disclosures
Orhun H. Kantarci, MD
PRESENTER
Dr. Kantarci has nothing to disclose.
Martina Novotna (Mayo Clinic) No disclosure on file
Brittani L. Conway, MD (University of Minnesota) No disclosure on file
No disclosure on file
M. M. Paz Soldan, MD, PhD (University of Utah) Dr. Paz Soldan has received personal compensation in the range of $500-$4,999 for serving as a Consultant for TG Therapeutics. The institution of Dr. Paz Soldan has received research support from National Institutes of Health. The institution of Dr. Paz Soldan has received research support from National Multiple Sclerosis Society. The institution of Dr. Paz Soldan has received research support from Western Institute for Biomedical Research. The institution of Dr. Paz Soldan has received research support from Biogen. The institution of Dr. Paz Soldan has received research support from Novartis. The institution of Dr. Paz Soldan has received research support from Clene Nanomedicine.
Nuhad Abou Zeid, MD (Wake Forest Baptist Medical Center) No disclosure on file
Nilufer Kale, MD Dr. Kale has nothing to disclose.
Melih Tutuncu, MD No disclosure on file